<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Interleukin-4 (IL-4) and interleukin-13 (IL-13) are anti-inflammatory and immunomodulatory cytokines which can influence <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-directed immunosurveillance </plain></SENT>
<SENT sid="1" pm="."><plain>Nothing is presently known about expression of these cytokines and their receptors (IL-4R and IL-13R) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to characterize their expression in primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> specimens and to evaluate possible functions for this disease </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Expression of IL-4, IL-13, IL-4R, and IL-13R protein was characterized by immunohistochemistry in 359 patients with Union for International <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Control stage I-III <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and evaluated by uni- and multivariate analysis for their prognostic relevance </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> four proteins were expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> specimens </plain></SENT>
<SENT sid="5" pm="."><plain>In the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, high IL-4, IL-13, IL-4R, and IL-13R immunoreactivity were present in 33 % (118/359), 50 % (181/359), 36 % (129/359), and 42 % (152/359), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with high expression of IL-4, IL-4R, and IL-13R had a lower frequency of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of IL-13 did not influence the frequency of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>However, high IL-13-immunoreactivity was associated with a better overall survival (p = 0.041) </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of IL-4, IL-4R, or IL-13R did not influence survival </plain></SENT>
<SENT sid="10" pm="."><plain>Multivariate analysis revealed that besides pT classification and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence, IL-13 expression was an independent prognostic factor for overall survival </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Expression of IL-4, IL-4R, and IL-13R are involved in the process of local <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, while IL-13 expression has an impact on survival </plain></SENT>
<SENT sid="12" pm="."><plain>These interleukins and their receptors may become attractive targets for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>